Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling

(2013) F. Wermeling et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

General mechanism for modulating immunoglobulin effector function

(2013) P. Sondermann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Emerging treatments for pemphigoid diseases

(2013) Ralf J. Ludwig et al.   TRENDS IN MOLECULAR MEDICINE

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fc  receptor for the amelioration of experimental ITP

(2012) D. Leontyev et al.   BLOOD

Activation of CD4+Foxp3+regulatory T cells proceeds normally in the absence of B cells during EAE

(2012) Kai Hoehlig et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo

(2012) Inessa Schwab et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1

(2012) Inessa Schwab et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Intravenous Immunoglobulin Prevents Murine Antibody-Mediated Acute Lung Injury at the Level of Neutrophil Reactive Oxygen Species (ROS) Production

(2012) John W. Semple et al.   PLoS One

Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin

(2012) Danila Leontyev et al.   TRANSFUSION

Epidermolysis bullosa acquisita: Autoimmunity to anchoring fibril collagen

(2011) Mei Chen et al.   AUTOIMMUNITY

Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up

(2011) A.R. Ahmed et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

(2011) Robert M. Anthony et al.   NATURE

Intravenous immunoglobulin therapy in rheumatic diseases

(2011) Jagadeesh Bayry et al.   Nature Reviews Rheumatology

Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice

(2010) H.-S. Huang et al.   BLOOD

Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

(2010) A. R. Crow et al.   BLOOD

The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

(2010) Mark Ballow   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Epidermolysis bullosa acquisita: What’s new?

(2010) Norito ISHII et al.   JOURNAL OF DERMATOLOGY

A defunctioning polymorphism inFCGR2Bis associated with protection against malaria but susceptibility to systemic lupus erythematosus

(2010) Lisa C. Willcocks et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology

(2009) H.-P. Hartung et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

New insight into the mechanism of action of IVIg: the role of dendritic cells

(2009) A. R. CROW et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Impaired inhibitory Fc  receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

(2009) B. Tackenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-Inflammatory Actions of Intravenous Immunoglobulin

(2008) Falk Nimmerjahn et al.   Annual Review of Immunology

Identification of a receptor required for the anti-inflammatory activity of IVIG

(2008) R. M. Anthony et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

(2008) R. M. Anthony et al.   SCIENCE

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

(2007) A. Ephrem et al.   BLOOD